US Stock MarketDetailed Quotes
SSKN Strata Skin Sciences
- 3.100
- +0.070+2.31%
Close Nov 5 16:00 ET
12.93MMarket Cap-1308P/E (TTM)
3.290High2.930Low13.94KVolume2.930Open3.030Pre Close43.48KTurnover0.83%Turnover RatioLossP/E (Static)4.17MShares6.96052wk High1.36P/B5.20MFloat Cap2.51352wk Low--Dividend TTM1.68MShs Float6120.000Historical High--Div YieldTTM11.88%Amplitude2.513Historical Low3.119Avg Price1Lot Size
Strata Skin Sciences Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -37.59%591K | 1.59%-804K | 43.83%-519K | 741.34%1.51M | -210.52%-2.16M | 1,791.07%947K | -131.44%-817K | -161.27%-924K | -73.24%179K | -253.54%-694K |
| Net income from continuing operations | 96.86%-99K | -18.80%-3.37M | -95.17%-10.83M | -2,271.25%-3.79M | -5.83%-1.05M | -66.38%-3.15M | -13.31%-2.84M | -105.06%-5.55M | 81.15%-160K | -90.98%-995K |
| Operating gains losses | --6K | --13K | 1,786.54%981K | --17K | 82.35%31K | ---- | ---- | 102.75%52K | --0 | 70.00%17K |
| Depreciation and amortization | -10.87%1.33M | -10.52%1.34M | 3.76%5.9M | -6.67%1.37M | 11.61%1.54M | 4.19%1.49M | 6.52%1.5M | 39.21%5.69M | 29.31%1.47M | 28.79%1.38M |
| Deferred tax | ---- | ---- | -400.00%-120K | ---- | ---- | ---- | ---- | 233.33%40K | ---- | ---- |
| Other non cash items | -7.14%39K | -24.39%31K | -10.83%140K | -31.71%28K | -27.50%29K | 7.69%42K | 10.81%41K | 324.32%157K | --41K | --40K |
| Change In working capital | -160.08%-793K | 242.45%839K | 97.61%-69K | 189.97%1.34M | -78.92%-2.97M | 3,100.00%1.32M | -19.41%245K | -990.43%-2.89M | -963.37%-1.49M | -250.95%-1.66M |
| -Change in receivables | 29.43%-295K | 15.97%726K | 112.31%141K | 129.70%267K | 54.68%-334K | -1,072.09%-418K | 39.73%626K | -133.67%-1.15M | -190.94%-899K | -117.40%-737K |
| -Change in inventory | -73.47%160K | -154.42%-154K | 151.42%689K | 274.28%1.03M | -71.31%-1.23M | 101.00%603K | 123.62%283K | -2,877.78%-1.34M | 204.55%276K | -307.95%-718K |
| -Change in prepaid assets | -150.57%-88K | -293.75%-31K | 321.62%246K | -14,100.00%-142K | 112.90%198K | 160.42%174K | -81.18%16K | -70.77%-111K | -100.56%-1K | 214.81%93K |
| -Change in payables and accrued expense | -142.22%-380K | 160.36%204K | -135.70%-297K | 229.91%582K | -1,947.44%-1.44M | 843.80%900K | -125.55%-338K | -52.10%832K | -138.52%-448K | -72.63%78K |
| -Change in other current liabilities | 23.08%-70K | -5.26%-100K | 21.17%-376K | 59.75%-97K | -138.46%-93K | 9.00%-91K | 2.06%-95K | -29.27%-477K | -156.38%-241K | 57.61%-39K |
| -Change in other working capital | -178.95%-120K | 178.54%194K | 26.71%-472K | -78.49%-307K | 79.23%-70K | 24.59%152K | 3.89%-247K | -45.05%-644K | 65.74%-172K | -381.43%-337K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -37.59%591K | 1.59%-804K | 43.83%-519K | 741.34%1.51M | -210.52%-2.16M | 1,791.07%947K | -131.44%-817K | -161.27%-924K | -73.24%179K | -253.54%-694K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 79.74%-345K | 59.54%-725K | -14.93%-5.02M | -9.06%-1.85M | 162.43%329K | -104.93%-1.7M | -36.79%-1.79M | 38.72%-4.37M | -50.35%-1.7M | 88.37%-527K |
| Net PPE purchase and sale | 79.74%-345K | 59.54%-725K | -34.34%-5.02M | -9.06%-1.85M | 162.43%329K | -104.93%-1.7M | -163.92%-1.79M | -2.27%-3.74M | -50.35%-1.7M | 50.14%-527K |
| Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 81.83%-631K | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 79.74%-345K | 59.54%-725K | -14.93%-5.02M | -9.06%-1.85M | 162.43%329K | -104.93%-1.7M | -36.79%-1.79M | 38.72%-4.37M | -50.35%-1.7M | 88.37%-527K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | -18K | 1,472.20%6.86M | 0 | -104K | 6.97M | 0 | -643.48%-500K | -500K | 0 |
| Net issuance payments of debt | ---- | ---- | --7M | --0 | --0 | ---- | ---- | --0 | --0 | --0 |
| Net other financing activities | --0 | ---18K | 72.20%-139K | --0 | ---104K | ---- | ---- | -275.94%-500K | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | ---18K | 1,472.20%6.86M | --0 | ---104K | --6.97M | --0 | -643.48%-500K | ---500K | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | 56.98%6.57M | 19.47%8.12M | -46.01%6.8M | -3.97%8.47M | 3.58%10.4M | -61.68%4.19M | -46.01%6.8M | -30.51%12.59M | -32.44%8.82M | -41.08%10.04M |
| Current changes in cash | -96.04%246K | 40.71%-1.55M | 122.85%1.32M | 82.82%-347K | -58.07%-1.93M | 800.00%6.21M | -56.89%-2.61M | -4.80%-5.79M | -338.18%-2.02M | 69.37%-1.22M |
| End cash Position | -34.42%6.82M | 56.98%6.57M | 19.47%8.12M | 19.47%8.12M | -3.97%8.47M | 3.58%10.4M | -61.68%4.19M | -46.01%6.8M | -46.01%6.8M | -32.44%8.82M |
| Free cash flow | 132.54%246K | 41.40%-1.53M | -18.84%-5.54M | 77.17%-347K | -49.55%-1.83M | 14.77%-756K | -152.81%-2.61M | -117.25%-4.66M | -229.72%-1.52M | -101.82%-1.22M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data